#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness VEXAS syndrome Rhabdomyosarcoma Craniocerebral injury Leiomyosarcoma Congenital generalised lipodystrophy Cholangiocarcinoma Pyruvate dehydrogenase complex deficiency Primary adrenal insufficiency Malformation venous Eosinophilic granulomatosis with polyangiitis Hereditary optic atrophy Autoimmune myositis Soft tissue sarcoma Gaucher's disease type I More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Life with Disease Adrenogenital syndrome – Trials in Disease Atypical haemolytic uraemic syndrome – Basic Information Paraneoplastic neurological syndrome – Life with Disease Combined immunodeficiency Angelman’s syndrome Prolymphocytic leukaemia – Basic Information SAPHO syndrome – Diagnostics Mitochondrial myopathy Ocular melanoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cat Epithelium Extract Rilpivirine Hydrochloride Anselamimab Lutetium (177Lu)-Neobomb1 Cemdisiran Human Coagulation Factor Ix Human Coagulation Factor Ii Human Cancellous Bone Semaglutide Evencaleucel Human Coagulation Factor Vii Budigalimab Trastuzumab Methylphenidate Hydrochloride Codeine Phosphate Betula Alba Pollen Extract Paroxetine GSKVX000000070965 Human Coagulation Factor Viii Bi 1839100 More therapies…

    Learn about Your Condition

    Meningococcal infection Cortical dysplasia Osteomyelitis Exudative retinopathy Malignant melanoma stage II Aphthous ulcer Atopic keratoconjunctivitis Hepatorenal syndrome Paedophilia Pulmonary congestion Prinzmetal angina Guttate psoriasis Stevens-Johnson syndrome Neurodermatitis Metastasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteosarcoma recurrent

  • Study on the Effectiveness and Safety of Regorafenib for Patients with Resistant Primary Bone Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma recurrent
    • Ewing’s sarcoma recurrent
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Regorafenib
    Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!